Robertson Stephens Wealth Management »

Relmada Therapeutics shares owned by Robertson Stephens Wealth Management

Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Robertson Stephens Wealth Management from 13F filings

Historical chart of Robertson Stephens Wealth Management investment in Relmada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relmada Therapeutics held by Robertson Stephens Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relmada Therapeutics by Robertson Stephens Wealth Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $50k 25k 2.01
2025-06-30 $15k 25k 0.60
2025-03-31 $6.8k 25k 0.27
2024-12-31 $13k 25k 0.52

More positions owned by Robertson Stephens Wealth Management

Applovin Corp Com Cl A (APP)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Specialized Funds Div App Etf (VIG)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Ishares Core Msci Emkt (IEMG)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Microsoft Corporation (MSFT)
Vanguard Index Fds Total Stk Mkt (VTI)
J P Morgan Exchange Traded F Betabuildrs Us (BBUS)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Rus 1000 Grw Etf (IWF)

View all positions for Robertson Stephens Wealth Management

Top funds holding Relmada Therapeutics

Ikarian Capital
Driehaus Capital Management
Boothbay Fund Management
Acadian Asset Management
BlackRock
Vanguard Group
AdvisorShares Investments
Geode Capital Management
Marshall Wace
Deutsche Bank Aktiengesellschaft
CI Private Wealth
Susquehanna International
Two Sigma Investments
Renaissance Technologies
Parsons Capital Management

View all funds holding Relmada Therapeutics